Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PreSERVE-AMI: AMR-001 in STEMI
NCT01495364Phase 2Completed
- Sponsor
- Lisata Therapeutics
- Start
- Dec 2011
- Primary completion
- Jun 2014
- Modality
- Stem Cell Therapies, Adoptive Cell Transfer
- Countries
- 1
01
Overview
A Phase 2 trial of AMR-001 in ST-elevation myocardial infarction (STEMI), sponsored by Lisata Therapeutics. Started Dec 2011; status: completed.
02
Drugs
AMR-001
03
Conditions
ST-elevation myocardial infarction (STEMI)
Beyond the preview
Go deeper on NCT01495364.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01495364.